BGLC vs POOL · rev $9.5M vs P/E 18, rev $5.31B
BioNexus Gene Lab Corp Common stock (BGLC) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported BGLC revenue for 2024-12-31 was $9.5M. Net income was $1.6M. Revenue was down 2.7% from 2023-12-31 to 2024-12-31. BGLC currently screens at market cap $6.1M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
BGLC currently screens at market cap $6.1M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the BGLC and POOL stock pages for the full models.
Not investment advice.